TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
HOLD
Tremendously well managed. While diversified by geography and business line. Had a huge run and he questions if he should start trimming. Would look to buy on any weakness.
PAST TOP PICK
(A Top Pick Oct 2/06. Up 12.2%.) Still owns, but has scaled back because she thinks it is going to hit a wall for a while.
WAIT
Basically at a 52-week high. It's at the top of the multiple ranges and had a recent move. Would try to buy it back in the $38 range.
BUY
A great long-term play. Great growth in the US and China.
HOLD
A great company. Fairly reasonably priced, particularly compared to the banks. The premium that insurance companies in general have traded at has shrunk.
BUY
Moderately undervalued according to his valuations. Profit growth rate is better than the market average. Good yield. Stable earnings and ROE history. A relatively defensive interest-rate sensitive name.
TOP PICK
Likes their Hancock acquisition giving exposure to the US, but more important is their Asian positioning. Well run company.
BUY
Has a massively positive franchise in North America. The John Hancock acquisition has been well integrated. Likes their Asian exposure. Expects to see solid earnings growth in future.
BUY
In terms of using financial services to access greater Asian exposure this is a company you might want to consider.
HOLD
One of his favourite companies, but wouldn't be putting new money into it. On a relative valuation basis, Sun Life (SLF-T) is a little bit better buy at this point in time.
BUY
Of all the financials, this one has the nicest chart. The banks all did fairly well with 10%-20% returns. This one did not have the same returns and has some catching up to do. Had a number of bottoms from June on and they were always higher. Also had a pretty steady top with a nice breakout in November.
PAST TOP PICK
(A Top Pick Dec 28/05. Up 15.2%.) Still likes, but sold his holdings. If you want to be in this space, use Sun Life (SLF-T).
WAIT
Probably fully priced here and would let it consolidate. Good solid company. Expecting a market correction in the next 2 to 3 months.
BUY
Favourite life insurance company in North America. Best prospects to grow. Expect them to make a major acquisition in the US to further their growth. The big kicker is their far east operations.
TOP PICK
(A Top Pick July 4/06. Up 6.8%.) A bit disappointed that they have lagged the financial group. A great company. Earnings next year will probably be double the growth rate of the banks. Management is superb. Well diversified globally.
Showing 1,831 to 1,845 of 2,283 entries